Differential Impact of LPG-and PG-Deficient Leishmania major Mutants on the Immune Response of Human Dendritic Cells.
BACKGROUND:Leishmania major infection induces robust interleukin-12 (IL12) production in human dendritic cells (hDC), ultimately resulting in Th1-mediated immunity and clinical resolution. The surface of Leishmania parasites is covered in a dense glycocalyx consisting of primarily lipophosphoglycan...
Saved in:
Main Authors: | Michelle A Favila (Author), Nicholas S Geraci (Author), Asha Jayakumar (Author), Suzanne Hickerson (Author), Janet Mostrom (Author), Salvatore J Turco (Author), Stephen M Beverley (Author), Mary Ann McDowell (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2015-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Leishmania major glycosylation mutants require phosphoglycans (lpg2-) but not lipophosphoglycan (lpg1-) for survival in permissive sand fly vectors.
by: Anna Svárovská, et al.
Published: (2010) -
Quantitative single-cell analysis of Leishmania major amastigote differentiation demonstrates variably extended expression of the lipophosphoglycan (LPG) virulence factor in different host cell types.
by: Michael A Mandell, et al.
Published: (2022) -
Fitness and Phenotypic Characterization of Miltefosine-Resistant Leishmania major.
by: Kimbra G Turner, et al.
Published: (2015) -
Vaccination with a Leishmania infantum HSP70-II null mutant confers long-term protective immunity against Leishmania major infection in two mice models.
by: José Carlos Solana, et al.
Published: (2017) -
Enhancing LPG adoption in Ghana (ELAG): a factorial cluster-randomized controlled trial to Enhance LPG Adoption & Sustained use
by: Daniel Carrión, et al.
Published: (2018)